Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease

Jake Le Suer, Rosemary Sease, Finn Hawkins, Amy L. Ryan

Source: Eur Respir Monogr 2021; 91: 190-204
Disease area: Airway diseases

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jake Le Suer, Rosemary Sease, Finn Hawkins, Amy L. Ryan. Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease. Eur Respir Monogr 2021; 91: 190-204

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021


Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015



Using induced pluripotent stem cells to model the human lung alveolar epithelium
Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Year: 2018

3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


Derivation of epithelial-only airway organoids from human pluripotent stem cells
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Embryonic stem cells generate airway epithelium
Source: Eur Respir J 2004; 24: Suppl. 48, 436s
Year: 2004

iPSC derived lung stem cells as tools to understand lung regeneration and disease
Source: ERS Lung Science Conference 2021
Year: 2021



Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Metabolic reprogramming by mesenchymal stem cells as a strategy for lung repair
Source: ERS Lung Science Conference 2020
Year: 2020


Mesenchymal cells, immune cells and the lung stem cell niche
Source: Eur Respir Monogr 2021; 91: 134-143
Year: 2021


Engineering distal pulmonary epithelium from induced pluripotent stem cell (iPSC)-derived alveolar cells
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019

PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021

Generation of an immortalized functional alveolar epithelial cell line originating from human induced pluripotent stem cells
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021


In search of ckit+ stem cells in lung tissue
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015